Literature DB >> 33611536

Biparietal bidirectional bipolar radiofrequency in hybrid cardiac ablation: an in vitro evaluation.

Francesco Matteucci1, Bart Maesen1, Carlo De Asmundis2, Elham Bidar1, Linda Micali1, Gianmarco Parise1, Jos G Maessen1, Mark La Meir1,2, Sandro Gelsomino1,2.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the lesion size and depth of radiofrequency (RF) ablation in a simultaneous biparietal bidirectional bipolar (SBB) approach, compared to a simultaneous and staged unipolar and uniparietal bipolar setup [simultaneous uniparietal bipolar (SiUB) and staged uniparietal bipolar (StUB), respectively].
METHODS: Fresh left atrial porcine tissue was mounted into the ABLA-BOX simulator. Different ablation approaches were tested: (i) SBB: a concept consisting of SBB endo-epicardial ablation, (ii) SiUB: simultaneous epicardial uniparietal bipolar and endocardial unipolar ablation and (iii) StUB: staged epicardial uniparietal bipolar and endocardial unipolar ablation. In the StUB setup, a 1-h interval between the epi-endo ablation was respected.
RESULTS: Transmural lesions were present in 90% of the bipolar biparietal ablations, yet no full transmurality was observed in the simultaneous nor in the staged unipolar with uniparietal bipolar ablation group. In SBB, the area and volume of the ablation lesions were smaller (523.33 mm2/mm and 52.33 mm3/mm, respectively) than in SiUB (588.17 mm2/mm and 58.81 mm3/mm, respectively) and StUB (583.76 mm2/mm and 58.37 mm3/mm, P = 0.044). Also, in SBB, the overall, epicardial and endocardial maximum diameters of the lesions (1.59, 1.57 and 1.52 mm; respectively) were smaller than in SiUB (2.38, 2.26 and 2.33 mm; respectively) and in StUB (2.36, 2.28 and 2.14 mm; respectively, all P < 0.001).
CONCLUSIONS: Although bipolar biparietal bidirectional RF ablation results in smaller lesions than uniparietal bipolar and unipolar ablation, their capacity to penetrate the tissue is much higher. Moreover, in uniparietal RF applications, the energy spreads in the superficial layers of the tissue but fails to penetrate. Therefore, the degree of transmurality is much higher when using such a 'truly bipolar' ablation approach.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  zzm321990 In vitro simulation; Bipolar ablation; Catheter ablation; Hybrid AF ablation; Image processing

Mesh:

Year:  2021        PMID: 33611536      PMCID: PMC8691503          DOI: 10.1093/icvts/ivab047

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  25 in total

1.  Lesion formation by ventricular septal ablation with irrigated electrodes: comparison of bipolar and sequential unipolar ablation.

Authors:  Koichi Nagashima; Ichiro Watanabe; Yasuo Okumura; Kimie Ohkubo; Masayoshi Kofune; Toshiyuki Ohya; Yuji Kasamaki; Atsushi Hirayama
Journal:  Circ J       Date:  2010-12-24       Impact factor: 2.993

Review 2.  Ablation technology for the surgical treatment of atrial fibrillation.

Authors:  Spencer J Melby; Richard B Schuessler; Ralph J Damiano
Journal:  ASAIO J       Date:  2013 Sep-Oct       Impact factor: 2.872

3.  Efficacy and safety of right and left atrial ablations on the beating heart with irrigated bipolar radiofrequency energy: a long-term animal study.

Authors:  Spencer J Melby; Sydney L Gaynor; Jordon G Lubahn; Anson M Lee; Paymon Rahgozar; Shelton D Caruthers; Todd A Williams; Richard B Schuessler; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 5.209

4.  Late outcomes after the Cox maze IV procedure for atrial fibrillation.

Authors:  Matthew C Henn; Timothy S Lancaster; Jacob R Miller; Laurie A Sinn; Richard B Schuessler; Marc R Moon; Spencer J Melby; Hersh S Maniar; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2015-08-08       Impact factor: 5.209

5.  Persistent atrial fibrillation: A systematic review and meta-analysis of invasive strategies.

Authors:  Wouter R Berger; Eva R Meulendijks; Jacqueline Limpens; Nicoline W E van den Berg; Jolien Neefs; Antoine H G Driessen; Sébastien P J Krul; Wim Jan P van Boven; Joris R de Groot
Journal:  Int J Cardiol       Date:  2018-11-29       Impact factor: 4.164

6.  Hybrid versus catheter ablation in patients with persistent and longstanding persistent atrial fibrillation: a systematic review and meta-analysis†.

Authors:  Claudia A J van der Heijden; Mindy Vroomen; Justin G Luermans; Rein Vos; Harry J G M Crijns; Sandro Gelsomino; Mark La Meir; Laurent Pison; Bart Maesen
Journal:  Eur J Cardiothorac Surg       Date:  2019-09-01       Impact factor: 4.191

7.  Successful performance of Cox-Maze procedure on beating heart using bipolar radiofrequency ablation: a feasibility study in animals.

Authors:  Sydney L Gaynor; Yosuke Ishii; Michael D Diodato; Sunil M Prasad; Kara M Barnett; Nicholas R Damiano; Gregory D Byrd; Samuel A Wickline; Richard B Schuessler; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2004-11       Impact factor: 4.330

8.  Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veins: a chronic animal study.

Authors:  Sunil M Prasad; Hersh S Maniar; Michael D Diodato; Richard B Schuessler; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

9.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

10.  Performance of a novel bipolar/monopolar radiofrequency ablation device on the beating heart in an acute porcine model.

Authors:  Lindsey L Saint; Christopher P Lawrance; Shoichi Okada; Toshinobu Kazui; Jason O Robertson; Richard B Schuessler; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2013 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.